Abstract
Scott Prudham and Angela Morris analyze the complex politics surrounding the regulation of agricultural biotechnology. Governments are subject to conflicting pressures in this area: on the one hand, to support the biotechnology industry, seen as an innovative and potentially transformative sector, and on the other, to respond to consumer concerns about the ethical, social, and safety implications of the new biotech products. Prudham and Morris examine government's attempt to mediate this conflict by considering the case of the Canadian Biotechnology Advisory Committee (CBAC) between 1999 and 2003. They argue that the CBAC GM foods project was, at best, a poorly conceived effort to engage with and respond to public concerns about GM foods, compromised by a prior commitment to commercialization.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
